[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): November 3, 2011 CLEANTECH SOLUTIONS INTERNATIONAL, INC. Delaware 001-34591 74-2235008 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, People’s Republic of China (86) 51083397559 Copies to: Asher S.]
[FORM 8-K CURRENT REPORTte of report (Date of earliest event reported):November 3, 2011 CLEANTECH SOLUTIONS INTERNATIONAL, Delaware 001-34591 74-2235008 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China]
[FORM 8-K CURRENT REPORTte of report (Date of earliest event reported):November 3, 2011 CLEANTECH SOLUTIONS INTERNATIONAL, Delaware 001-34591 74-2235008 (State or other jurisdiction oforporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China]
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported):November 3, 2011 CLEANTECH SOLUTIONS INTERNATIONAL, INC. Delaware 001-34591 74-2235008 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China]
[Company Contact FOR RELEASE ON NOVEMBER 7, 2011 AT 4:20 p.m. EST (New York) China Biologic Reports Third Quarter 2011 Results TAI'AN, Shandong Province, China, November 7, 2011 China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China (PRC), today reported its financial results for] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 7, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]
[FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported):November 3, 2011 CLEANTECH SOLUTIONS INTERNATIONAL, INC. Delaware 001-34591 74-2235008 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employee Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, Peoples Republic of China]
[Company Contact FOR RELEASE ON NOVEMBER 7, 2011 AT 4:20 p.m. EST (New York) China Biologic Reports Third Quarter 2011 Results TAI'AN, Shandong Province, China, November 7, 2011 China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China (PRC), today reported its financial results for] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 7, 2011 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former address, if changed]
[] [] []
[SOHU.COM REPORTS THIRD QUARTER 2011 UNAUDITED FINANCIAL RESULTS Record Total Revenues of US$233 Million, Up 42% Year-over-Year, Exceeding the High End of Group Guidance by US$3 Million; GAAP Net Income Before Non-Controlling Interest Up 19% Year-over-Year to US$64 Million, Non-GAAP Net Income Before Non-Controlling Interest Up 13% Year-over-Year to US$69 Million, Exceeding the High End of Group Guidance by US$2] []
